Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 385.75
-13.45 (-3.37%)
Jul 31, 2026, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 153.63 billion as of July 31, 2026. Its market cap has decreased by -46.55% in one year.
Market Cap
153.63B
Enterprise Value
145.32B
Revenue
36.00B
Ranking
n/a
PE Ratio
70.58
Stock Price
385.75
ChartMarket Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 153.63B, an increase of 147.35%. That is a compound annual growth rate of 8.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 153.63B | -40.72% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.78T |
| Divi's Laboratories | 2.14T |
| Apollo Hospitals Enterprise | 1.29T |
| Cipla | 1.19T |
| NATCO Pharma | 164.24B |
| Cohance Lifesciences | 162.61B |
| Alembic Pharmaceuticals | 156.67B |
| Rainbow Children's Medicare | 154.93B |